In vitro and in vivo antimicrobial activity of water-soluble chitosan oligosaccharides against Vibrio vulnificus

International Journal of Molecular Medicine

Volumn 24, Issue 3, 2009, Pages 327-333

  Lee, Byung Cheol ^a   Kim, Myun Soo ^a   Choi, Sang Ho ^b   Kim, Kwang Yoon ^c   Kim, Tae Sung ^a  

^a Korea University   (South Korea)

^b Seoul National University   (South Korea)

^c Chonnam National University   (South Korea)

Author keywords

Antimicrobial activity; Chitosan oligosaccharide; Vibrio vulnificus

Indexed keywords

ANTIBIOTIC AGENT; CHITOSAN OLIGOSACCHARIDE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; CHITOSAN; OLIGOSACCHARIDE; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERIAL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTESTINE EPITHELIUM; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL TIME; VIBRIO VULNIFICUS; VIBRIO VULNIFICUS INFECTION; ANIMAL; CELL DEATH; CELL LINE; CHEMISTRY; CYTOLOGY; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; INSTITUTE FOR CANCER RESEARCH MOUSE; INTESTINE CELL; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; SOLUBILITY; SURVIVAL; TIME; VIBRIOSIS;

ANIMALS; ANTI-BACTERIAL AGENTS; CELL DEATH; CELL LINE; CHITOSAN; ENTEROCYTES; FEMALE; HUMANS; MICE; MICE, INBRED ICR; MICROBIAL SENSITIVITY TESTS; OLIGOSACCHARIDES; SOLUBILITY; SURVIVAL ANALYSIS; TIME FACTORS; VIBRIO INFECTIONS; VIBRIO VULNIFICUS; WATER;

EID: 70349561461     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000236     Document Type: Article

References (37)

1. Ikeda T, Kanehara S, Ohtani T and Furukawa F: Endotoxin shock due to Vibrio vulnificus infection. Eur J Dermatol 16: 423-427, 2006.
2. Powell JL, Wright AC, Wasserman SS, Hone DM and Morris JG Jr: Release of tumor necrosis factor alpha in response to Vibrio vulnificus capsular polysaccharide in vivo and in vitro models. Infect Immun 65: 3713-3718, 1997.
3. Wright AC, Powell JL, Kaper JB and Morris JG Jr: Identification of a group 1-like capsular polysaccharide operon for Vibrio vulnificus. Infect Immun 69: 6893-6901, 2001.
4. Simpson LM and Oliver JD: Siderophore production by Vibrio vulnificus. Infect Immun 41: 644-649, 1983.
5. Gray LD and Kreger AS: Purification and characterization of an extracellular cytolysin produced by Vibrio vulnificus. Infect Immun 48: 67-72, 1985.
6. Gulig PA, Bourdage KL and Starks AM: Molecular Pathogenesis of Vibrio vulnificus. J Microbiol 43: 118-131, 2005.
7. Lee JH, Kim MW, Kim BS, Kim SM, Lee BC, Kim TS and Choi SH: Identification and characterization of the Vibrio vulnificus rtxA essential for cytotoxicity in vitro and virulence in mice. J Microbiol 45: 146-152, 2007.
8. Lee BC, Lee JH, Kim MW, Kim BS, Oh MH, Kim KS, Kim TS and Choi SH: Vibrio vulnificus rtxE is important for virulence, and its expression is induced by exposure to host cells. Infect Immun 76: 1509-1517, 2008.
9. Lee BC, Choi SH and Kim TS: Vibrio vulnificus RTX toxin plays an important role in the apoptotic death of human intestinal epithelial cells exposed to Vibrio vulnificus. Microbes Infect 10: 1504-1513, 2008.
10. Espat NJ, Auffenberg T, Abouhamze A, Baumhofer J, Moldawer LL and Howard RJ: A role for tumour necrosis factor-α in the increased mortality associated with Vibrio vulnificus infection in the presence of hepatic dysfunction. Ann Surg 223: 428-433, 1996.
11. Shin SH, Shin DH, Ryu PY, Chung SS and Rhee JH: Pro-inflammatory cytokine profile in Vibrio vulnificus septicemic patients' sera. FEMS Immunol Med Microbiol 33: 133-138, 2002.
12. Suh JK and Matthew HW: Application of chitosan-based polysaccharide biomaterials in cartilage tissue engineering: a review. Biomaterials 21: 2589-2598, 2000.
13. Peluso G, Petillo O and Ranieri M: Chitosan-mediated stimulation of macrophage function. Biomaterials 15: 1215-1220, 1994.
14. Usami Y, Okamoto Y, Minami S, Matsuhashi A, Kumazawa NH, Tanioka S and Shigemasa Y: Chitin and chitosan induce migration of bovine polymorphonuclear cells. J Vet Med Sci 56: 761-762, 1994.
15. Usami Y, Okamoto Y, Minami S, Matsuhashi A, Kumazawa NH, Tanioka S and Shigemasa Y: Migration of canine neutrophils to chitin and chitosan. J Vet Med Sci 56: 1215-1216, 1994.
16. Usami Y, Okamoto Y, Takayama T, Shigemasa Y and Minami S: Chitin and chitosan stimulate canine polymorphonuclear cells to release leukotriene B4 and prostaglandin E2. J Biomed Mater Res 42: 517-522, 1998.
17. Kim TH, Jin H, Kim HW, Cho MH and Cho CS: Mannosylated chitosan nanoparticle-based cytokine gene therapy suppressed cancer growth in BALB/c mice bearing CT-26 carcinoma cells. Mol Cancer Ther 5: 1723-1732, 2006.
18. Qi L and Xu Z: In vivo antitumor activity of chitosan nanoparticles. Bioorg Med Chem Lett 16: 4243-4245, 2006.
19. Maeda Y and Kimura Y: Antitumor effects of various low-molecular-weight chitosans are due to increased natural killer activity of intestinal intraepithelial lymphocytes in sarcoma 180-bearing mice. J Nutr 134: 945-950, 2004.
20. Schlievert PM: Chitosan malate inhibits growth and exotoxin production of toxic shock syndrome-inducing Staphylococcus aureus strain and group A streptococci. Antimicrob Agents Chemother 51: 3056-3062, 2007.
21. Tré-Hardy M, Vanderbist F, Traore H and Devleeschouwer MJ: In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures. Int J Antimicrob Agents 31: 329-336, 2008.
22. Seyfarth F, Schliemann S, Elsner P and Hipler UC: Antifungal effect of high- and low-molecular-weight chitosan hydrochloride, carboxymethyl chitosan, chitosan oligosaccharide and N-acetyl-D-glucosamine against Candida albicans, Candida krusei and Candida glabrata. Int J Pharm 353: 139-148, 2008.
23. Hossain S, Rahman A, Kabir Y, Shams AA, Afros F and Hashimoto M: Effects of shrimp (Macrobracium rosenbergii)-derived chitosan on plasma lipid profile and liver lipid peroxide levels in normo- and hypercholesterolaemic rats. Clin Exp Pharmacol Physiol 34: 170-176, 2007.
24. Geremias R, Pedrosa RC, Locatelli C, de Fávere VT, Coury-Pedrosa R and Laranjeira MC: Lipid lowering activity of hydrosoluble chitosan and association with Aloe vera L. and Brassica olearaceae L. Phytother Res 20: 288-293, 2006.
25. Sumiyoshi M and Kimura Y: Low molecular weight chitosan inhibits obesity induced by feeding a high-fat diet long-term in mice. J Pharm Pharmacol 58: 201-207, 2006.
26. Wang P, Jiang X, Jiang Y, Hu X, Mou H, Li M and Guan H: In vitro antioxidative activities of three marine oligosaccharides. Nat Prod Res 21: 646-654, 2007.
27. Zhong Z, Ji X, Xing R, Liu S, Guo Z, Chen X and Li P: The preparation and antioxidant activity of the sulfanilamide derivatives of chitosan and chitosan sulfates. Bioorg Med Chem 15: 3775-3782, 2007.
28. Cho MH, No HK and Prinyawiwatkul W: Chitosan treatments affect growth and selected quality of sunflower sprouts. J Food Sci 73: S70-S77, 2008.
29. Moon JS, Kim HK, Koo HC, Joo YS, Nam HM, Park YH and Kang MI: The antibacterial and immunostimulative effect of chitosan-oligosaccharides against infection by Staphylococcus aureus isolated from bovine mastitis. Appl Microbiol Biotechnol 75: 989-998, 2007.
30. Kim SK and Rajapakse N: Enzymatic production and biological activities of chitosan oligosaccharides (COS): A review. Carbohydr Polym 62: 357-368, 2005.
31. Jeon YJ and Kim SK: Chitosan derivatives killed bacteria by disrupting the outer and inner membrane. J Agric Food Chem 54: 6629-6633, 2006.
32. Yoon HJ, Moon ME, Park HS, Im SY and Kim YH: Chitosan oligosaccharide (COS) inhibits LPS-induced inflammatory effects in RAW 264.7 macrophage cells. Biochem Biophys Res Commun 358: 954-959, 2007.
33. Linkous DA and Oliver JD: Pathogenesis of Vibrio vulnificus. FEMS Microbiol Lett 174: 207-214, 1999.
34. Strom MS and Paranjpye RN: Epidemiology and pathogenesis of Vibrio vulnificus. Microbes Infect 2: 177-188, 2000.
35. Tharanathan RN and Kittur FS: Chitin - the undisputed biomolecule of great potential. Crit Rev Food Sci Nutr 43: 61-87, 2003.
36. Vishu Kumar AB, Varadaraj MC, Gowda LR and Tharanathan RN: Characterization of chito-oligosaccharides prepared by chitosanolysis with the aid of papain and Pronase, and their bactericidal action against Bacillus cereus and Escherichia coli. Biochem J 391(Pt 2): 167-175, 2005.
37. Kim WH, Goo SY, Shin MH, Chun SJ, Lee H, Lee KH and Park SJ: Vibrio vulnificus-induced death of Jurkat T-cells requires activation of p38 mitogen-activated protein kinase by NADPH oxidase-derived reactive oxygen species. Cell Immunol 253: 81-91, 2008.